Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6919964 | 7531347 | F | 6919964-7 | 20100802 | 20100811 | 20100811 | EXP | PHHO2010TR11662 | NOVARTIS PHARMACEUTICAL CORPORATION | 58 | YR | M | Y | 20100811 | MD | TURKEY |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6919964 | 1014396132 | PS | TASIGNA | 1 | ORAL | 800 MG, BID | 022068 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6919964 | 1014396132 | GASTROINTESTINAL STROMAL TUMOUR |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6919964 | DE |
| 6919964 | HO |
| 6919964 | LT |
Reactions reported
| Event ID | PT |
|---|---|
| 6919964 | EPILEPSY |
| 6919964 | MALIGNANT NEOPLASM PROGRESSION |
| 6919964 | METASTASES TO CENTRAL NERVOUS SYSTEM |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6919964 | 1014396132 | 20100724 | 20100802 | 10 | DAY |